RIVERNORTH CAPITAL MANAGEMENT, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 50 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RIVERNORTH CAPITAL MANAGEMENT, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$1,760,072
+1.6%
172,0500.0%0.08%
+9.0%
Q4 2022$1,732,544
+2.2%
172,0500.0%0.08%
+2.6%
Q3 2022$1,696,000
+1.2%
172,0500.0%0.08%
+11.8%
Q2 2022$1,676,000
-0.2%
172,0500.0%0.07%
+7.9%
Q1 2022$1,679,000
-1.7%
172,050
-1.7%
0.06%
-8.7%
Q4 2021$1,708,000
-0.2%
174,9850.0%0.07%
-24.2%
Q3 2021$1,711,000174,9850.09%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2023
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 141,317$1,448,4992.02%
Atalaya Capital Management LP 500,000$5,115,0001.63%
MMCAP International Inc. SPC 800,000$8,184,0001.61%
ANGELO GORDON & CO., L.P. 300,000$3,069,0000.77%
FIR TREE CAPITAL MANAGEMENT LP 792,269$8,104,9120.64%
Castle Creek Arbitrage, LLC 530,000$5,421,9000.60%
683 Capital Management, LLC 699,000$7,150,7700.53%
GLAZER CAPITAL, LLC 850,590$8,7020.48%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$5,125,0000.45%
METEORA CAPITAL, LLC 366,183$3,746,0520.44%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders